Oragenics, Inc. (LON: 0A64)
London
· Delayed Price · Currency is GBP · Price in USD 0.300
+0.018 (6.21%)
At close: Jan 21, 2025
Oragenics Revenue
In the year 2023, Oragenics had annual revenue of $37.65K USD, down -71.37%.
Revenue
$37.65K
Revenue Growth
-71.37%
P/S Ratio
n/a
Revenue / Employee
$7.53K
Employees
5
Market Cap
2.82M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 221.41B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| BP p.l.c. | 144.69B |
| British American Tobacco p.l.c. | 26.18B |